Zai Lab Ltd — Regulatory Filings 2017

Aug 30, 2017

F-6 1 e616533_f6-zailab.htm

As filed with the Securities and Exchange Commission on August 30, 2017 Registration No. 333 -

Field: Rule-Page

Field: /Rule-Page

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Field: Rule-Page

Field: /Rule-Page

FORM F-6

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933 FOR AMERICAN DEPOSITARY SHARES EVIDENCED BY

AMERICAN DEPOSITARY RECEIPTS

Field: Rule-Page

Field: /Rule-Page

Zai Lab Limited

(Exact name of issuer of deposited securities as specified in its charter)

Field: Rule-Page

Field: /Rule-Page

Not Applicable

(Translation of issuer’s name into English)

Field: Rule-Page

Field: /Rule-Page

Cayman Islands

(Jurisdiction of incorporation or organization of issuer )

Field: Rule-Page

Field: /Rule-Page

CITIBANK, N.A.

(Exact name of depositary as specified in its charter )

Field: Rule-Page

Field: /Rule-Page

388 Greenwich Street

New York, New York 10013

(877) 248-4237

(Address, including zip code, and telephone number, including area code, of depositary’s principal executive offices)

Field: Rule-Page

Field: /Rule-Page

Law Debenture Corporate Services Inc.

801 2 nd Avenue, Suite 403

New York, New York 10017

(212) 750-6474

(Address, including zip code, and telephone number, including area code, of agent for service)

Field: Rule-Page

Field: /Rule-Page

Copies to:

Patrick O’Brien, Esq. Ropes & Gray LLP Prudential Tower 800 Boylston Street Boston, MA 02199-3600 Samantha Du Chief Executive Officer Zai Lab Limited 4560 Jinke Rd Bldg.1, Fourth Floor Pudong Shanghai, China 201210 Herman H. Raspé, Esq. Patterson Belknap Webb & Tyler LLP 1133 Avenue of the Americas New York, NY 10036

Field: Rule-Page

Field: /Rule-Page

| It is proposed that this filing become effective
under Rule 466: | immediately upon filing. |
| --- | --- |
| ☐ | on (Date) at (Time). |

If a separate registration statement has been filed to register the deposited shares, check the following box : ☒

Field: Rule-Page

Field: /Rule-Page

CALCULATION OF REGISTRATION FEE

Title of Each Class of Securities to be Registered	Amount to be Registered	Proposed Maximum Aggregate Price Per Unit*	Proposed Maximum Aggregate Offering Price**	Amount of Registration Fee
American Depositary Shares ( ADS(s) ), each ADS representing the right to receive one ordinary share of Zai Lab Limited	100,000,000 ADSs	$5.00	$5,000,000	$579.50
*
Each unit represents 100 ADSs. **
Estimated solely for the purpose of calculating the registration fee. Pursuant to Rule 457(k), such estimate is
computed on the basis of the maximum aggregate fees or charges to be imposed in connection with the issuance of
ADSs.
The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, or until this Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.

Field: Page; Sequence: 1

Field: Sequence; Type: LowerRoman; Name: PageNo i Field: /Sequence

Field: /Page

This Registration Statement may be executed in any number of counterparts, each of which shall be deemed an original, and all of such counterparts together shall constitute one and the same instrument.

Field: Page; Sequence: 2

Field: Sequence; Type: LowerRoman; Name: PageNo ii Field: /Sequence

Field: /Page

PART I

INFORMATION REQUIRED IN PROSPECTUS

Cross Reference Sheet

Item 1. DESCRIPTION OF SECURITIES TO BE REGISTERED

Item Number and Caption — 1.	Name of Depositary and address of its principal executive office		Location in Form of American Depositary Receipt (“ Receipt ”) Filed Herewith as Prospectus — Face of Receipt - Introductory Article.
2.	Title of Receipts and identity of deposited securities		Face of Receipt - Top Center.
	Terms of Deposit:
	(i)	The amount of deposited securities
represented by one American Depositary Share ("ADSs")	Face of Receipt - Upper right corner.
	(ii)	The procedure for voting, if any, the deposited securities	Reverse of Receipt - Paragraphs (17) and (18).
	(iii)	The collection and distribution of
dividends	Reverse of Receipt - Paragraph (15).
	(iv)	The transmission of notices, reports and proxy soliciting material	Face of Receipt - Paragraph (14); Reverse of Receipt – Paragraph (17) and (18).
	(v)	The sale or exercise of rights	Reverse of Receipt – Paragraphs (15) and
(17).
	(vi)	The deposit or sale of securities resulting from dividends, splits or plans of reorganization	Face of Receipt - Paragraph (6); Reverse of Receipt - Paragraphs (15), (17) and
(19).

Field: Page; Sequence: 3

I-1

Field: /Page

| Item
Number and Caption | (vii) | Amendment, extension or termination of the deposit agreement | Location in Form of American Depositary Receipt (“ Receipt ”) Filed Herewith as Prospectus — Reverse of Receipt - Paragraphs (23) and (24)
(no provision for extensions). |
| --- | --- | --- | --- |
| | (viii) | Rights of holders of Receipts to
inspect the transfer books of the Depositary and the list of holders of ADSs | Face of Receipt - Paragraph (14). |
| | (ix) | Restrictions upon the right to deposit or withdraw the underlying securities | Face of Receipt – Paragraphs (2), (4), (6), (7),
(9) and (10). |
| | (x) | Limitation upon the liability of the Depositary | Face of Receipt - Paragraph (8); Reverse of Receipt - Paragraphs (20) and (21). |
| 3. | Fees and charges which may be imposed directly or indirectly on holders of ADSs | | Face of Receipt - Paragraph (11). |
| Item 3. | | AVAILABLE INFORMATION | Face of Receipt - Paragraph (14). |

Zai Lab Limited is subject to the periodic reporting requirements of the United States Securities Exchange Act of 1934, as amended, and, accordingly, files certain reports with, and submits certain reports to, the United States Securities and Exchange Commission (the “ Commission ”). These reports can be retrieved from the Commission’s internet website (www.sec.gov), and can be inspected and copied at the public reference facilities maintained by the Commission at 100 F Street, N.E., Washington D.C. 20549.

Field: Page; Sequence: 5; Value: 1

I- Field: Sequence; Type: Arabic; Name: PageNo 2 Field: /Sequence

Field: /Page

PROSPECTUS

The Prospectus consists of the proposed form of American Depositary Receipt included as Exhibit A to the Form of Deposit Agreement filed as Exhibit (a) to this Registration Statement on Form F-6 and is incorporated herein by reference.

Field: Page; Sequence: 6; Value: 1

I- Field: Sequence; Type: Arabic; Name: PageNo 3 Field: /Sequence

Field: /Page

PART II

INFORMATION NOT REQUIRED IN PROSPECTUS

Item 3. EXHIBITS

(a) Form of Deposit Agreement, by and among Zai Lab Limited (the “ Company ”), Citibank, N.A., as depositary (the “ Depositary ”), and all Holders and Beneficial Owners of American Depositary Shares issued thereunder (“ Deposit Agreement ”). ___ Filed herewith as Exhibit (a).

(b) Any other agreement to which the Depositary is a party relating to the issuance of the American Depositary Shares registered hereunder or the custody of the deposited securities represented thereby. ___ None.

(c) Every material contract relating to the deposited securities between the Depositary and the issuer of the deposited securities in effect at any time within the last three years. ___ None.

(d) Opinion of counsel for the Depositary as to the legality of the securities to be registered. ___ Filed herewith as Exhibit (d).

(e) Certificate under Rule 466. ___ None.

(f) Powers of Attorney for certain officers and directors and the authorized representative of the Company. ___ Set forth on the signature pages hereto.

Field: Page; Sequence: 7; Options: NewSection; Value: 1

II- Field: Sequence; Type: Arabic; Name: PageNo 1 Field: /Sequence

Field: /Page

Item 4. UNDERTAKINGS

(a) The Depositary undertakes to make available at the principal office of the Depositary in the United States, for inspection by holders of ADSs, any reports and communications received from the issuer of the deposited securities which are both (1) received by the Depositary as the holder of the deposited securities, and (2) made generally available to the holders of the underlying securities by the issuer.

(b) If the amount of fees charged is not disclosed in the prospectus, the Depositary undertakes to prepare a separate document stating the amount of any fee charged and describing the service for which it is charged and to deliver promptly a copy of such fee schedule without charge to anyone upon request. The Depositary undertakes to notify each registered holder of an ADS thirty (30) days before any change in the fee schedule.

Field: Page; Sequence: 8; Value: 1

II- Field: Sequence; Type: Arabic; Name: PageNo 2 Field: /Sequence

Field: /Page

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, Citibank, N.A., acting solely on behalf of the legal entity created by the Deposit Agreement, by and among Zai Lab Limited, Citibank, N.A., as depositary, and all Holders and Beneficial Owners from time to time of American Depositary Shares to be issued thereunder, certifies that it has reasonable grounds to believe that all the requirements for filing on Form F-6 are met and has duly caused this Registration Statement on Form F-6 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York, on the 30 th day of August 2017.

| Legal entity created
by the Deposit Agreement under which the American Depositary Shares registered hereunder are to be issued, each American Depositary
Share representing the right to receive one ordinary share of Zai Lab Limited | |
| --- | --- |
| CITIBANK,
N.A., solely in its capacity as Depositary | |
| By: | /s/ Keith Galfo |
| | Name: Keith Galfo |
| | Title: Vice President |

Field: Page; Sequence: 9; Value: 1

II- Field: Sequence; Type: Arabic; Name: PageNo 3 Field: /Sequence

Field: /Page

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, Zai Lab Limited certifies that it has reasonable grounds to believe that all the requirements for filing on Form F-6 are met and has duly caused this Registration Statement on Form F-6 to be signed on its behalf by the undersigned thereunto duly authorized, in Shanghai, China, on August 30, 2017.

| Zai
Lab Limited | |
| --- | --- |
| By: | /s/ Samantha Du |
| | Name: Samantha Du |
| | Title: Chief Executive Officer |

Field: Page; Sequence: 10; Value: 1

II- Field: Sequence; Type: Arabic; Name: PageNo 4 Field: /Sequence

Field: /Page

POWERS OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS , that each person whose signature appears below constitutes and appoints each of Samantha Du, Tom Feng, and Marietta Wu to act as his/her true and lawful attorney-in-fact and agent, with full power of substitution, for him/her and in his/her name, place and stead, in any and all such capacities, to sign any and all amendments, including post-effective amendments, and supplements to this Registration Statement, and to file the same, with all exhibits thereto and other documents in connection therewith, with the United States Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as s/he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his/her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement on Form F-6 has been signed by the following persons in the following capacities on August 30, 2017.

Signature	Title
/s/ Samantha Du	Chief Executive Officer, Chairman of the Board of Directors
Samantha Du	(Principal Executive Officer)
/s/ Tom Feng	Vice President, Finance (Principal Financial and Accounting
Officer)
Tom Feng
/s/ John Diekman	Director
John Diekman
/s/ Tao Fu	Director
Tao Fu
/s/ Nisa Leung	Director
Nisa Leung

Field: Page; Sequence: 11

II-5

Field: /Page

Signature	Title
/s/ Peter Wirth	Director
Peter Wirth
/s/ Marietta Wu	Director
Marietta Wu
/s/ Jianming Yu	Director
Jianming Yu
Law Debenture Corporate
Services Inc.	Authorized Representative in the United States
/s/ Giselle Manon
Name: Giselle Manon Title: Service of Process Officer

Field: Page; Sequence: 12

II-6

Field: /Page

Index to Exhibits

Exhibit	Document
(a)	Form of Deposit Agreement
(d)	Opinion of counsel to the Depositary